Zymeworks
ZYME
171 hedge funds and large institutions have $713M invested in Zymeworks in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 65 increasing their positions, 39 reducing their positions, and 17 closing their positions.
88% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 17
67% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 39
21% more call options, than puts
Call options by funds: $906K | Put options by funds: $750K
9% more funds holding
Funds holding: 157 → 171 (+14)
2% less capital invested
Capital invested by funds: $724M → $713M (-$11.5M)
3.56% less ownership
Funds ownership: 99.61% → 96.05% (-3.6%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$9.9M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$6.65M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
+$4.56M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.87M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$51.2M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$4.53M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$2.55M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.18M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$2.18M |
ZYME Hedge Fund Activity: Q1 2024 in Review
171 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2024, worth a combined $713M — down 1.6% from $724M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new ZYME positions and 17 closed out — a net gain of 15 holders — while 65 added to existing stakes and 39 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $9.9M. The largest seller was Morgan Stanley, cutting an estimated $51.2M.
- 171 institutional investors held Zymeworks (ZYME) as of Q1 2024, up from 157 in Q4 2023.
- Funds reported $713M of Zymeworks stock for Q1 2024, down 1.6% quarter-over-quarter.
- 32 funds opened new Zymeworks positions in Q1 2024 and 17 closed out, a net change of +15 holders.
- The largest Zymeworks buyer in Q1 2024 was Citadel Advisors, an estimated $9.9M added.
- The largest Zymeworks seller in Q1 2024 was Morgan Stanley, an estimated $51.2M sold.
Based on aggregated 13F filings for Q1 2024.